Mechanistically, PRMT7 loss resulted in reduced expression of glycine decarboxylase, leading to the reprogramed glycine metabolism to generate methylglyoxal, which is detrimental to leukemia stem cells. The gene discussed is PRMT7; the disease is leukemia.